Bronchiectasis trials in Netherlands
7 of 7 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 13 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleThe AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
- Where
- Alkmaar, Amsterdam, Rotterdam, The Hague, Utrecht, Zutphen
- Age
- 12 years and over
- People
- 1,755 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06872892 · EU 2024-518589-29-00 - Phase 3Not yet taking people in NetherlandsA Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON)
- Where
- Alkmaar, Amsterdam, Rotterdam, The Hague, Utrecht, Zutphen
- Age
- 12 years and over
- People
- 1,500 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07915219 · EU 2026-527086-30-00 - Phase 1Taking peopleDrug-drug interaction study of midazolam and brensocatib
- Where
- Groningen
- Age
- 18 years to 64 years
- People
- 26
- Run by
- Insmed Inc.
See details and how to join2026-526670-16-00 - Phase 2Taking peopleDose Range Finding, Efficacy, and Safety Study of Nebulized CSL787 in Adults With Non-cystic Fibrosis Bronchiectasis (NCFB)
- Where
- Alkmaar, Amsterdam, Eindhoven, Hoofddorp, Nijmegen, Rotterdam, Zutphen
- Age
- 18 years to 85 years
- People
- 180 worldwide
- Run by
- CSL Behring
See details and how to joinNCT07048262 · EU 2024-518821-13-00 - Phase 2Taking peopleA Study to Evaluate the Efficacy, Safety, and PK of AZD0292 Administered IV in Participants 12 Years of Age and Older With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization
- Where
- Amsterdam, Rotterdam, Zutphens
- Age
- 12 years and over
- People
- 435 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07088926 - Phase 2Taking peopleA trial to learn how well AZD0292 works, how safe it is, and how it moves throughout the body over time in people with bronchiectasis and chronic PsA colonization
- Where
- Amsterdam, Rotterdam, Zutphen
- Age
- 18 years and over
- People
- 112 worldwide
- Run by
- AstraZeneca AB
See details and how to join2025-523009-14-00 - Phase 1Taking peopleFirst in Human Trial of CTX-187 in Healthy Volunteers and Chronically Infected Patients
- Where
- Groningen
- Age
- 18 years to 65 years
- People
- 104
- Run by
- Centauri Therapeutics Limited
See details and how to joinNCT07708116 · EU 2026-525619-15-00